Literature DB >> 27177840

Neither Maximum Tumor Size nor Solid Component Size Is Prognostic in Part-Solid Lung Cancer: Impact of Tumor Size Should Be Applied Exclusively to Solid Lung Cancer.

Aritoshi Hattori1, Takeshi Matsunaga1, Kazuya Takamochi1, Shiaki Oh1, Kenji Suzuki2.   

Abstract

BACKGROUND: We aimed to investigate the prognostic impact of tumor size based on the consolidation status by thin-section computed tomography.
METHODS: We evaluated 1,181 surgically resected clinical N0 M0 non-small cell lung carcinomas. Consolidation tumor ratio (CTR) was evaluated for all, and tumors were classified into three groups, namely pure ground-glass opacity (CTR = 0; n = 168), part-solid (0 < CTR < 1.0; n = 448), and solid (CTR = 1.0; n = 565). The impact of tumor size was assessed based on CTR using Cox proportional hazards model.
RESULTS: Tumor size significantly differentiated the 5-year overall survival (≤20 mm; n = 638: 93.4%; 21-30 mm; n = 284: 84.2%; 31-50 mm; n = 193: 69.3%; ≥51 mm; n = 66: 43.5%; p < 0.0001). When we evaluated the impact of tumor size based on CTR, the 5-year overall survival differed significantly in patients with radiologic solid lung cancer (≤20 mm: 83.0%; 21-30 mm: 75.4%; 31-50 mm: 56.2%; ≥51 mm: 45.3%; p < 0.0001). In contrast, it did not affect the 5-year overall survival in patients with radiologic pure ground-glass opacity (100% regardless of the tumor sizes) and part-solid lung cancer (≤20 mm: 97.7%; 21-30 mm: 94.6%; 31-50 mm: 93.4%; p = 0.1028; 0 < CTR ≤ 0.5: 98.4%; 0.5 < CTR < 1.0: 95.0%; p = 0.1247). Furthermore, maximum tumor size (p = 0.6370), solid component size (p = 0.2340), and CTR (p = 0.1395) were not associated with poor overall survival in radiologic part-solid lung cancer.
CONCLUSIONS: The impact of maximum tumor size should be applied only to radiologic solid lung cancer without the ground-glass opacity component on thin-section computed tomography. On the other hand, we recommend that pure ground-glass opacity and part-solid lung cancers be described, respectively, as clinical-Tis and clinical-T1a, which are independent of maximum tumor size and solid component size on thin-section computed tomography.
Copyright © 2016 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27177840     DOI: 10.1016/j.athoracsur.2016.02.074

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  27 in total

1.  Neither the maximum tumor size nor solid component size is prognostic in part-solid lung cancer: to be ground-glass opacity or not to be, is that really the question?

Authors:  Kimihiro Shimizu; Yoichi Ohtaki; Seshiru Nakazawa; Akira Mogi; Hiroyuki Kuwano
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

2.  Adenocarcinoma containing lepidic growth.

Authors:  Hisashi Iwata
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

3.  CT-Guided Core Biopsy for Peripheral Sub-solid Pulmonary Nodules to Predict Predominant Histological and Aggressive Subtypes of Lung Adenocarcinoma.

Authors:  Ping-Chung Tsai; Yi-Chen Yeh; Po-Kuei Hsu; Chun-Ku Chen; Teh-Ying Chou; Yu-Chung Wu
Journal:  Ann Surg Oncol       Date:  2020-05-03       Impact factor: 5.344

4.  How to manage patients with subcentimeter non-small cell lung cancer?

Authors:  Tomoyoshi Takenaka
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895

5.  Surgical outcome of wide wedge resection in poor-risk patients with clinical-N0 non-small cell lung cancer.

Authors:  Hiroaki Tsunezuka; Daishiro Kato; Satoru Okada; Tatsuo Furuya; Junichi Shimada; Masayoshi Inoue
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-07-26

6.  Interobserver size measurement variability in part-solid lung adenocarcinoma using pre-operative computed tomography.

Authors:  Kazutoshi Hamanaka; Hiroki Takayama; Tsutomu Koyama; Shunichiro Matsuoka; Tetsu Takeda; Hiroyuki Agatsuma; Kyoko Yamada; Akira Hyogotani; Satoshi Kawakami; Ken-Ichi Ito
Journal:  J Thorac Dis       Date:  2019-07       Impact factor: 2.895

7.  The impact of histology and ground-glass opacity component on volume doubling time in primary lung cancer.

Authors:  Kai Obayashi; Kimihiro Shimizu; Seshiru Nakazawa; Toshiteru Nagashima; Toshiki Yajima; Takayuki Kosaka; Jun Atsumi; Natsuko Kawatani; Tomohiro Yazawa; Kyoichi Kaira; Akira Mogi; Hiroyuki Kuwano
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

8.  Significance of preoperative biopsy in radiological solid-dominant clinical stage I non-small-cell lung cancer.

Authors:  Chien-Sheng Huang; Hung-Che Chien; Chun-Ku Chen; Yi-Chen Yeh; Po-Kuei Hsu; Hui-Shan Chen; Chih-Cheng Hsieh; Han-Shui Hsu; Biing-Shiun Huang; Chun-Che Shih
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-04-19

9.  Characteristics of Ground-Glass Nodules Detected by Low-Dose Computed Tomography as a Regular Health Examination Among Chinese Hospital Employees and Their Parents.

Authors:  Bihan Ouyang; Maoyuan Li; Li Li; Shaohui Liu; Min Li
Journal:  Front Oncol       Date:  2021-04-27       Impact factor: 6.244

10.  Prognostic prediction of clinical stage IA lung cancer presenting as a pure solid nodule.

Authors:  Jong Hui Suh; Jae Kil Park; Youngkyu Moon
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.